biospecimen_aliquot__bcr_aliquot_barcode	tcga-ac-a2fo-01a-11d-a17w-09
biospecimen_aliquot__bcr_aliquot_uuid	588bf255-b3bd-4247-9d39-9c1172260e5e
biospecimen_aliquot__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
biospecimen_aliquot__bcr_sample_barcode	tcga-ac-a2fo-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0113417806
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2011-08-31
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	2
biospecimen_aliquot__plate_id	a17w
biospecimen_aliquot__plate_row	e
biospecimen_aliquot__quantity	2.80
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ac-a2fo-01a-11d
biospecimen_analyte__bcr_analyte_uuid	4d1295fb-1d56-49d8-9633-9e9a21f3d261
biospecimen_analyte__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
biospecimen_analyte__bcr_sample_barcode	tcga-ac-a2fo-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ac-a2fo
biospecimen_diagnostic_slides__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ac-a2fo-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	46929316-d7ed-4d69-b068-409bffbcec4d
biospecimen_normal_control__bcr_patient_barcode	tcga-ac-a2fo
biospecimen_normal_control__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
biospecimen_portion__bcr_portion_barcode	tcga-ac-a2fo-01a-11
biospecimen_portion__bcr_portion_uuid	b3444a01-0d8f-401e-bcfb-ea5f76ca2e1b
biospecimen_portion__bcr_sample_barcode	tcga-ac-a2fo-01a
biospecimen_portion__date_of_creation	2011-07-01
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ac-a2fo-01a-11d
biospecimen_protocol__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
biospecimen_protocol__bcr_sample_barcode	tcga-ac-a2fo-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
biospecimen_sample__bcr_sample_barcode	tcga-ac-a2fo-01a
biospecimen_sample__bcr_sample_uuid	6ab6c7d7-a0b5-4830-94a3-f16bc11ef953
biospecimen_sample__days_to_collection	2051
biospecimen_sample__initial_weight	120
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-ac-a2fo.5a7eb73f-e681-46cc-b2d6-c87eeab0ac99.pdf
biospecimen_sample__pathology_report_uuid	5a7eb73f-e681-46cc-b2d6-c87eeab0ac99
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
biospecimen_slide__bcr_sample_barcode	tcga-ac-a2fo-01a
biospecimen_slide__bcr_slide_barcode	tcga-ac-a2fo-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	5b0133e0-0452-4c64-92a0-ee26ef1a18e2
biospecimen_slide__image_file_name	tcga-ac-a2fo-01a-01-ts1.5b0133e0-0452-4c64-92a0-ee26ef1a18e2.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	10
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	30
biospecimen_slide__percent_stromal_cells	19
biospecimen_slide__percent_tumor_cells	50
biospecimen_slide__percent_tumor_nuclei	60
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ac-a2fo
biospecimen_tumor_sample__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
clinical_drug__bcr_drug_barcode	tcga-ac-a2fo-d43227
clinical_drug__bcr_drug_uuid	74e898d7-9552-4550-9764-4f924fc55872
clinical_drug__bcr_patient_barcode	tcga-ac-a2fo
clinical_drug__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
clinical_drug__form_completion_date	2013-5-15
clinical_drug__pharmaceutical_therapy_drug_name	hormone, nos
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	225
clinical_drug__treatment_best_response	complete response
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-ac-a2fo-f43223
clinical_follow_up__bcr_followup_uuid	ef71a0d0-16ab-45a4-a42d-625afef971b8
clinical_follow_up__bcr_patient_barcode	tcga-ac-a2fo
clinical_follow_up__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2013-5-15
clinical_follow_up__last_contact_days_to	2255
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	65
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n1
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	other (specify)
clinical_patient__axillary_staging_method_other	sentinel lymph node plus level i and level ii lymph nodes
clinical_patient__bcr_patient_barcode	tcga-ac-a2fo
clinical_patient__bcr_patient_uuid	f5d4c2d3-cc69-4b38-8551-0917e3622a68
clinical_patient__birth_days_to	-23928
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-9-21
clinical_patient__gender	female
clinical_patient__her2_fish_status	indeterminate
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2005
clinical_patient__last_contact_days_to	1542
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	10
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a2fo
clinical_patient__pr_status_by_ihc	negative
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	ac
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AC-A2FO-01A-11D-A17W-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AC-A2FO-01A-11D-A17W-09.bed.meta
manually_curated__id	tcga-ac-a2fo-01a-11d-a17w-09
manually_curated__md5sum	7ef5e4309d346916305327287a2a11dd
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	588bf255-b3bd-4247-9d39-9c1172260e5e
manually_curated__tumor_tag	brca
